Oruka Therapeutics, Inc. · XETR:HQ1

Oruka Therapeutics, Inc. financial statements

Oruka Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue000000000
Cost of revenue83.0K27.0K111.0K114.0K91.0K93.0K89.0K22.0K27.0K24.0K
Gross profit-83.0K-27.0K-111.0K-114.0K-91.0K-93.0K-89.0K-22.0K-27.0K-24.0K
Research and development100.6M75.1M1.01M4.75M13.8M4.99M1.83M4.24M14.1M12.3M
Selling, general and administrative21.4M
Operating income-122.1M-88.1M-7.30M-10.6M-19.3M-9.77M-5.81M-8.12M-18.7M-16.6M
Depreciation and amortization83.0K27.0K15.0K20.0K16.0K8.00K18.0K22.0K27.0K24.0K
EBITDA-122.0M-88.1M-7.28M-10.6M-19.3M-9.76M-5.80M-8.10M-18.7M-16.6M
Interest expense01.47M9.00K7.00K8.00K6.00K
Income before tax-105.4M-83.7M-5.34M-9.93M-19.3M-9.75M-5.65M-7.96M-18.6M-16.4M
Income tax000-9.00K-167.0K-31.0K-61.0K0
Net income-105.4M-83.7M-5.34M-9.93M-19.3M-9.74M-5.48M-7.93M-18.5M-16.4M
Earnings per share, basic-2.16-4.99-0.37-0.69-1.39-2.07-4.15-10.31-1.77-1.81
Earnings per share, diluted-0.37-0.69-1.39-2.07-4.15-10.31-1.77-1.81

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents46.9M61.6M37.4M42.4M53.4M49.1M8.36M6.61M8.70M7.40M
Short-term investments290.1M314.1M3.05M13.8M
Current assets343.9M376.9M37.6M42.7M54.4M50.0M8.48M6.78M12.3M21.4M
Property, plant and equipment288.0K10.0K25.0K48.0K21.0K10.0K24.0K42.0K66.0K
Total assets488.6M396.0M37.9M43.1M54.9M50.4M8.54M6.83M12.4M24.6M
Accounts payable4.16M3.46M362.0K334.0K1.12M1.77M418.0K230.0K622.0K1.21M
Current liabilities15.4M13.0M637.0K1.13M3.50M3.50M926.0K793.0K2.07M2.40M
Total debt1.93M968.0K00000000
Total liabilities16.7M13.8M841.0K1.41M3.88M3.91M926.0K793.0K2.09M2.44M
Shareholders' equity471.9M382.2M37.0M41.7M51.0M46.5M7.61M6.03M10.3M22.2M
Shares outstanding48.7M16.8M14.5M14.4M14.4M9.55M1.59M773.6K11.8M9.08M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-88.2M-57.8M-5.01M-10.9M-18.8M-7.72M-4.80M-8.24M-17.5M-15.0M
Capital spending-209.0K-189.0K0-2.00K-43.0K-19.0K-4.00K-4.00K-3.00K-12.0K
Free cash flow-88.4M-58.0M-5.01M-10.9M-18.8M-7.74M-4.80M-8.25M-17.5M-15.0M
Cash from investing-96.7M-330.1M0-2.00K-43.0K-19.0K-4.00K3.05M12.9M-16.4M
Cash from financing170.3M449.5M0023.1M48.5M6.56M3.10M5.85M
Change in cash-14.6M24.1M-5.01M-10.9M4.29M40.7M1.75M-2.09M1.30M-31.4M